QSI Logo

Quantum-Si incorporated (QSI) 

NASDAQ
Market Cap
$78.57M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
152 of 774
Rank in Industry
95 of 432

Largest Insider Buys in Sector

QSI Stock Price History Chart

QSI Stock Performance

About Quantum-Si incorporated

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

Insider Activity of Quantum-Si incorporated

Over the last 12 months, insiders at Quantum-Si incorporated have bought $376,707 and sold $13,096 worth of Quantum-Si incorporated stock.

On average, over the past 5 years, insiders at Quantum-Si incorporated have bought $189,936 and sold $466,050 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Kummeth Charles R. (director) — $296,918. Keyes Jeffry R. (Chief Financial Officer) — $123,965. Hawkins Jeffrey Alan (President & CEO) — $65,273.

The last purchase of 31,100 shares for transaction amount of $27,533 was made by Kummeth Charles R. (director) on 2024‑08‑12.

List of Insider Buy and Sell Transactions, Quantum-Si incorporated

2024-09-24SaleChief Product Officer
2,117
0.0015%
$0.93$1,970-2.87%
2024-09-23SaleChief Product Officer
2,192
0.0016%
$0.95$2,073-9.84%
2024-08-12Purchasedirector
31,100
0.0231%
$0.89$27,533+8.75%
2024-08-09PurchasePresident & CEO
25,000
0.0169%
$0.85$21,273+1.59%
2024-08-09PurchaseGeneral Counsel & Corp. Secr.
25,000
0.0172%
$0.86$21,610+1.59%
2024-08-09PurchaseChief Financial Officer
50,000
0.0346%
$0.87$43,465+1.59%
2024-08-09Purchasedirector
138,900
0.0961%
$0.87$120,926+1.59%
2024-06-24SaleChief Commercial Officer
3,169
0.0022%
$1.20$3,790-24.56%
2024-06-21SaleChief Commercial Officer
4,359
0.0025%
$1.21$5,262-23.85%
2024-03-15PurchaseGeneral Counsel & Corp. Secr.
10,000
0.0071%
$1.74$17,400-32.18%
2024-03-14PurchasePresident & CEO
25,000
0.0169%
$1.76$44,000-33.15%
2024-03-05PurchaseChief Financial Officer
50,000
0.0351%
$1.61$80,500-18.63%
2023-03-15PurchaseGeneral Counsel & Corp. Secr.
20,000
0.0144%
$1.77$35,400-6.21%
2022-12-15Saledirector
89,000
0.0636%
$2.15$191,234-19.53%
2022-08-17PurchaseGeneral Counsel & Corp. Secr.
20,000
0.0147%
$3.93$78,526-43.88%
2022-06-14PurchaseInterim CEO
25,561
0.0183%
$3.10$79,175-25.64%
2022-06-13SaleEVP, Product Development & Ops
1,648
0.0013%
$3.22$5,307-21.21%
2022-06-13SaleChief Business Officer
1,622
0.0013%
$3.22$5,223-21.21%
2022-03-14SaleChief Operating Officer
6,581
0.0049%
$4.01$26,374-23.58%
2022-03-14SaleChief Business Officer
6,478
0.0049%
$4.01$25,961-23.58%

Insider Historical Profitability

<0.0001%
Hawkins Jeffrey AlanPresident & CEO
1003757
1.5445%
$1.2120
LaPointe ChristianGeneral Counsel & Corp. Secr.
571710
0.8797%
$1.2142<0.0001%
Keyes Jeffry R.Chief Financial Officer
446820
0.6875%
$1.2120
Kummeth Charles R.director
355000
0.5462%
$1.2120
ROTHBERG JONATHAN MInterim CEO
2568443
3.952%
$1.2110<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
ARK Investment Management LLC$25.15M912.77M-17.72%-$5.42M0.09
Sumitomo Mitsui Trust Holdings$15.87M5.688.05M-5.61%-$942,475.580.01
Nikko Asset Management Americas Inc$15.71M5.688.05M-5.61%-$932,907.310.12
BlackRock$14.25M5.17.23M-2.05%-$298,604.72<0.0001
The Vanguard Group$10.44M3.745.3M+1.58%+$162,452.12<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.